Equitable Q2: Strong fees & investment income; derivatives and reinsurance fuel GAAP volatility

Quick take - Equitable Holdings, Inc. (NYSE: EQH)

What's happening inside: management is actively managing market risks and capital - buying AB units, executing share repurchases and issuing subordinated debt - while running a large hedging program and completing reinsurance/novation actions that materially affected results. The business shows healthy fee and investment income but big mark-to-market swings from derivatives and market-risk benefits (MRBs) continue to drive net-income volatility.

Key facts & numbers (Q2 2025 / YTD unless noted)
* Total revenues (Q2): $2,362 million; Six months: $6,938 million.
* Net derivative gains (losses) (Q2): $(1,374) million; Six months: $(575) million.
* Net investment income (Q2): $1,355 million; Six months: $2,603 million.
* Investment gains (losses), net (Q2): $(71) million; Six months: $(85) million.
* Net income (loss) (Q2): $(283) million; Six months: $(133) million.
* Net income (loss) attributable to Holdings (Q2): $(349) million; Six months: $(286) million.
* Net income available to common (Q2): $(367) million; EPS basic (Q2): $(1.21); diluted: $(1.21).
* Non‑GAAP Operating Earnings (Q2): $352 million; Six months: $773 million; trailing‑12‑month Non‑GAAP operating ROE: 21.1%.
* Total assets (June 30, 2025): $303,088 million; Total liabilities: $300,125 million; Total equity: $2,605 million.
* Cash & cash equivalents (June 30, 2025): $14,957 million (up from $6,964 at 12/31/24).
* Policyholders' account balances: $123,359 million (June 30, 2025) vs $110,929 million (12/31/24).
* Separate Accounts assets: $131,683 million; Asset Management AUM (June 30, 2025): $829.1 billion.
* Long‑term debt (June 30, 2025): $4,332 million. Junior subordinated debt issued March 26, 2025: $500 million.
* Share repurchases Q2 2025: 4.77 million shares at avg $51.71; remaining buyback authorization ≈ $1.5 billion (as of 6/30/25).
* Notable one‑time / prior quarter items: Novation loss recorded Q1 2025 = $499 million pre‑tax (total after AOCI impact ≈ $236 million).
* Subsequent event (post‑quarter): RGA Reinsurance Transaction closed July 31, 2025 (transfers 75% quota share of certain in‑force life blocks to RGA) - important de‑risking step.

Positive aspects of the income statement / business
* Strong recurring fee base - investment management & service fees remain resilient: $1,272 million Q2, $2,557 million YTD.
* Net investment income increased year‑over‑year: Q2 up to $1,355 million (benefits from larger average balances and alternatives income).
* Non‑GAAP operating earnings are positive: $352 million in Q2 and $773 million YTD, indicating core business profitability after stripping market‑timing noise.
* Liquidity improved at the parent: cash and equivalents $14.96 billion (6/30/25) and financing actions (junior subordinated debt issued, available credit facilities, AB distributions) strengthened funding flexibility.
* Strategic moves to reduce risk: AB tender purchases increased economic ownership (~68.6% after exchanges) and the RGA reinsurance closed (subsequent), transferring material life‑block risk to reinsurer.

Negative aspects / risks shown in the income statement
* Large derivative volatility: Q2 net derivative losses $(1,374)M were the single largest drag on GAAP net income this quarter - derivatives and MRB fair‑value swings produce erratic GAAP results.
* Significant MRB and reinsurance accounting effects: the novation and reinsurance arrangements produced big, lumpy pre‑tax hits (e.g., $499M novation loss in Q1) and changes in AOCI that complicate earnings comparability.
* Rising policyholder costs: Interest credited to policyholders and policyholders' benefits rose materially (interest credited Q2 = $796M; benefits Q2 = $787M), pressuring margins for certain products.
* Unrealized losses / AOCI pressure in investment portfolio: AFS fixed maturities amortized cost $86,819M vs fair value $80,094M - gross unrealized losses significant (AOCI remains negative: Accumulated other comprehensive income attributable to Holdings $(7,432)M).
* Earnings are sensitive to market moves and actuarial assumptions - GAAP earnings can flip with equity/interest‑rate moves, making quarter‑to‑quarter comparability difficult.
* Regulatory and capital constraints: Equitable Financial had limited Ordinary Dividend capacity per NYDFS formula (affects parent dividend capability); statutory rules (Reg 213 and NAIC developments) and evolving SVO/CLO treatments can change capital requirements.

What to watch next
* Impact of the RGA reinsurance closed 7/31/25 on statutory capital, MRBs and future GAAP volatility (expected to materially de‑risk blocks).
* How hedging and static statutory hedges behave in different market scenarios - they reduce economic risk but increase derivative notional and potential GAAP swings.
* AFS fixed‑maturity recoveries or further unrealized losses - affects AOCI and deferred tax valuation allowances (valuation allowance was $258M at 6/30/25).
* AB performance and distributions given increased economic interest (~68.6%) and the April tender / July exchange activity.
* Share buyback cadence vs retention of capital for statutory requirements and future reinsurance / M&A needs.

Bottom line: Equitable (NYSE: EQH) runs a diversified, fee‑and‑asset driven business that is generating healthy recurring investment and fee income, but GAAP reported profits remain volatile because of large derivative and MRB mark‑to‑market swings and discrete reinsurance/novation impacts. Management is actively reshaping risk exposure (RGA reinsurance, AB transactions) and returning capital (buybacks), while regulatory and market‑driven accounting volatility are the key near‑term uncertainties.